<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=182969788831632&amp;ev=PageView&amp;noscript=1">

Blog

Voicebrook

Recent Posts by Voicebrook:

Pathology News Roundup: June 30, 2020

CAP: Stop E/M Cuts

The College of American Pathologists launched a campaign of advocacy demanding that Congress delay, mitigate, or cancel the -8 percent Medicare cut for pathology services that will take effect in January 2021. Congress can stop this cut by waiving budget neutrality for Medicare changes to evaluation and management (E/M) services.

PathPod: A Pathology Podcast for Everyone

When life gives you lemons, make some lemonade. When life gives you a pandemic, make a pathology podcast.

That was the goal of Dr. Kamran Mirza, Dr. Sara Jiang, Dr. Michael Arnold, and Dr. Christina Arnold. These four pathologists are the dream team behind PathPod, a new podcast focused on blending friendship, entertainment, and education in the field of pathology. When COVID-19 hit and typical life ground to a halt, they took advantage of the interruption to their work schedules to launch PathPod, recording episodes over Zoom meetings and embracing their virtual connections.

Pathology News Roundup: June 16, 2020

CAP Annual Meeting Going Virtual

Every year, pathologists come together as friends and colleagues at the College of American Pathologists' annual meeting, but this year will be different due to the pandemic.  The CAP has announced that CAP20 will be held virtually.

Pathology News Roundup: June 2, 2020

Celebrating Women in Pathology

There are many women in pathology making significant contributions to the field. The American Society for Investigative Pathology (ASIP) gathered detailed profiles on a number of these accomplished women to celebrate Women in Pathology Month. 

Pathology News Roundup: May 19, 2020

New CAP Guidelines: Lung Specimens

The College of American Pathologists (CAP) has released new guidelines for lung specimens to help ensure that patients get the best diagnostic testing. Patients battling lung disease are frequently diagnosed through minimally invasive procedures that allow clinicians to perform vital ancillary tests on increasingly small specimens. But how small is too small? What is considered adequate for ancillary testing? And what are the essential steps to ensure that an adequate specimen is collected?